Macquarie Maintains Outperform on Pediatrix Medical Group, Raises Price Target to $20
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Macquarie analyst Tao Qiu maintains Pediatrix Medical Group (NYSE:MD) with a Outperform and raises the price target from $19 to $20.
Macquarie analyst Tao Qiu maintains Pediatrix Medical Group (NYSE:MD) with a Outperform and raises the price target from $19 to $20.